Mounjaro, a weight loss drug launched by Eli Lilly in India, could be a game-changer and has been making waves lately. Here's ...

Eli Lilly’s Global CEO David Ricks revealed that the pharma giant might manufacture its weight-loss blockbuster, Mounjaro, in ...

Eli Lilly CEO David Ricks reveals that developing a new drug costs around $4 billion before marketing. In an exclusive ...

GLP-1 receptor agonists, originally introduced in 2006, have undergone significant advancements over the years. David Ricks, ...

Now, Eli Lilly, the largest pharmaceutical company in the world in terms of market capitalisation, has launched its own ...

Mounjaro is a very big opportunity, given that a significant number of people have diabetes in India, says the CEO ...

With approximately 101 million individuals living with diabetes, increasing access to insulin and advanced treatments is ...

Semaglutide, branded as Rybelsus, Wegovy or Mounjaro, most popularly identified by Ozempic (as branded by Danish pharma giant ...

Zerodha CEO Nithin Kamath described weight-loss drugs Ozempic and Mounjaro as near 'miracle drugs,' highlighting their ...

While the weight loss results were impressive across the group, the cost and side effects remain important barriers for ...

Eli Lilly plans to turn India into a growth market by addressing its diabetes and obesity challenges with its new treatment, ...

In a nation where the battle against the stomach bulge is as intense as the love for butter parathas, a new player has ...